1. Home
  2. IOVA vs RBCAA Comparison

IOVA vs RBCAA Comparison

Compare IOVA & RBCAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.09

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Republic Bancorp Inc.

RBCAA

Republic Bancorp Inc.

HOLD

Current Price

$79.68

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
RBCAA
Founded
2007
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2008
1998

Fundamental Metrics

Financial Performance
Metric
IOVA
RBCAA
Price
$4.09
$79.68
Analyst Decision
Buy
Hold
Analyst Count
10
1
Target Price
$9.00
N/A
AVG Volume (30 Days)
13.1M
57.7K
Earning Date
05-07-2026
04-23-2026
Dividend Yield
N/A
2.41%
EPS Growth
14.84
N/A
EPS
N/A
0.77
Revenue
N/A
$417,495,000.00
Revenue This Year
$47.74
$3.93
Revenue Next Year
$40.31
N/A
P/E Ratio
N/A
$103.29
Revenue Growth
N/A
8.50
52 Week Low
$1.67
$63.97
52 Week High
$5.63
$79.80

Technical Indicators

Market Signals
Indicator
IOVA
RBCAA
Relative Strength Index (RSI) 61.90 64.35
Support Level $2.05 $67.02
Resistance Level $4.27 N/A
Average True Range (ATR) 0.27 1.51
MACD 0.03 0.16
Stochastic Oscillator 87.50 80.54

Price Performance

Historical Comparison
IOVA
RBCAA

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking, which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending, and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans, and receipt and payment of federal.

Share on Social Networks: